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Abstract
Background: Frailty is widely recognised as a distinct multifactorial clinical syndrome that implies vulnerability.
The links between frailty and adverse outcomes such as death and institutionalisation have been widely evidenced.
There is currently no gold standard frailty assessment tool; optimizing the assessment of frailty in older people
therefore remains a research priority. The objective of this systematic review is to identify existing multi-component
frailty assessment tools that were specifically developed to assess frailty in adults aged ≥60 years old and to
systematically and critically evaluate the reliability and validity of these tools.
Methods: A systematic literature review was conducted using the standardised COnsensus‐based Standards for
the selection of health Measurement INstruments (COSMIN) checklist to assess the methodological quality of
included studies.
Results: Five thousand sixty-three studies were identified in total: 73 of which were included for review. 38
multi-component frailty assessment tools were identified: Reliability and validity data were available for 21 %
(8/38) of tools. Only 5 % (2/38) of the frailty assessment tools had evidence of reliability and validity that was within
statistically significant parameters and of fair-excellent methodological quality (the Frailty Index-Comprehensive
Geriatric Assessment [FI-CGA] and the Tilburg Frailty Indicator [TFI]).
Conclusions: The TFI has the most robust evidence of reliability and validity and has been the most extensively
examined in terms of psychometric properties. However, there is insufficient evidence at present to determine
the best tool for use in research and clinical practice. Further in-depth evaluation of the psychometric properties
of these tools is required before they can fulfil the criteria for a gold standard assessment tool.
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Background
It is estimated that between the years 2000 and 2050,
the percentage of the world’s population over 60 years
old will double from 11 to 22 % [1]. Frailty is considered
one of the most complex and important issues associ-
ated with human ageing, with significant implications
for both patient outcomes and healthcare service utilisa-
tion. The links between frailty and increased risk of
adverse outcomes such as falls, loss of functional inde-
pendence, decreased quality of life, institutionalisation and
mortality have been clearly evidenced [2–7].
A recent systematic review of frailty prevalence world-
wide concluded that 10.7 % of community dwelling adults
aged ≥65 years were frail and 41.6 % pre-frail [8]. It was
noted that prevalence figures varied substantially between
studies (ranging from 4.0 to 59.1 %), with studies applying
a physical phenotypical definition of frailty consistently
reporting lower prevalence rates than those utilising a
broader definition of frailty which included psychosocial
domains [8]. This highlights the potential disparities in the
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identification of frailty depending on the definition of
frailty applied.
The issue of identifying frailty is compounded by
the fact that there is currently no universally accepted
operational definition of frailty. A recent Delphi methods
based consensus statement on frailty concluded that
additional research into clinical and laboratory biomarkers
of frailty is needed before an operational definition of
frailty can be achieved [9]. However, expert agreement
was reached on the basic theoretical underpinnings of
frailty; the results of which were reflective of the defining
characteristics of frailty for which there is a consensus in
the literature. It is widely recognised that frailty is a
distinct multifactorial clinical syndrome or state that is
separate from, but often associated with, disease and
disability [9–11]. Frailty is considered to be a dynamic,
non-linear process characterised by decreased reserves
and resistance resulting in poor maintenance of physio-
logical homeostasis [10–12]. The dynamic nature of the
frailty syndrome gives rise to the potential for preventative
and restorative interventions.
Many models have been suggested to conceptualise
frailty, however, at present there is no gold standard.
The two models which have the largest evidence-base
and are the most widely accepted are the Cardiovascular
Health Study (CHS) Phenotype Model [13] and the
Canadian Study of Health and Ageing (CSHA) Cumula-
tive Deficit Model [14]. The CHS Phenotype Model
[13] establishes a frailty phenotype with 5 variables
(involuntary weight loss, self-reported exhaustion, slow
gait speed, weak grip strength and self-reported seden-
tary behaviour), whereas the CSHA Cumulative Deficit
Model [14] measures frailty via an index of age-related
deficits including diseases and disabilities.
A wide variety of tools to screen for, diagnose and
measure frailty have been developed based on models of
frailty. However, at present no existing assessment tool
is considered to be of a gold standard. In view of the
predicted rise in the world’s older adult population, the
prevalence of frailty in this population, the evidenced
links between frailty and adverse outcomes, and the
potential for preventative and restorative interventions,
the accurate assessment of frailty remains a significant
clinical and research priority.
Six systematic reviews regarding the assessment of
frailty have been published to date [15–20]. One review
focused on the identification of frailty assessment tools
[15]. Two reviews focused on the diagnostic test accuracy
of frailty assessment tools; one reviewed the accuracy of
simple measures to assess frailty [16] and one reviewed
the sensitivity, specificity and predictive validity of instru-
ments based on major theoretical views of frailty [17]. A
further review examined the criterion validity, construct
validity and responsiveness specifically of Frailty Indexes
[18]. These reviews focused on the appraisal of a specific
subset of frailty assessment tools and did not examine all
aspects of validity or explore the reliability of the tools
identified. Only two reviews have reported an evaluation
of both the reliability and validity of frailty assessment
tools [19, 20]; the literature searches for which were com-
pleted in February 2010 and May 2011, respectively. Given
the current vast expansion of the frailty literature, an
updated review in this area is justified. The evaluation of
psychometric properties was not the sole focus in either
review [19, 20]. An in-depth evaluation of all available
reliability and validity data for existing frailty assessment
tools; including an assessment of both the methodological
quality of the evidence presented and the statistical signifi-
cance of the results has not been completed. Further, both
of these earlier reviews included studies which reported
the assessment of frailty via tools that were developed to
assess alternative constructs such as disability rather than
frailty per se. Tools that have been developed to assess
alternate constructs will be based on alternative concep-
tual models and frameworks that do not represent all
aspects of frailty; resulting in limited construct validity
when applied to the measurement of frailty. Also, where a
tool has been developed to measure a concept that is
distinct from but linked to frailty, such as disability, there
is a significant chance of confounding of the assessments
results, leading to the inaccurate assessment and diagnosis
of frailty based on disability factors alone. The inclusion of
such tools in a review limits the conclusions that can
be drawn in specific reference to the assessment of
frailty. One review also included studies involving single-
component assessment tools such as grip strength as a
single measure [19]. Given the multifactorial and complex
nature of the frailty syndrome, a tool to assess frailty
should be multicomponent to capture this multifactorial
complexity and grounded within a robust evidence-based
model of frailty. Tools originally created to assess an
alternative concept but later applied to frailty assess-
ment suggest a lack of theoretical robustness, as does
the application of a single-component assessment tool
to assess a multifactorial clinical syndrome. Conse-
quently, the aims of this review were to: Systematically
and critically evaluate the available evidence concerning
the reliability and validity of multi-component frailty
assessment tools that were specifically developed to
assess frailty in older adult populations; establishing the
tool with the best evidence to support its use in both
research and clinical settings.
Methods
Search strategy
The following databases were searched on March 30
2015: Medline (1946–present), PsychINFO (1806–present),
Embase (1947–present) and the Cochrane Central Register
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of Controlled Trials. The search strategy used was:
frailty AND (older OR elder* OR geriatr*) AND (meas-
ure* OR assess*). The reference lists of previous reviews
concerning the measurement of frailty were also searched
manually [15–20].
Selection criteria
Studies were selected for inclusion for review if they met
the following criteria:
 Study participants were aged ≥60 years old.
 The study described a multi-component tool (de-
fined as a tool that assesses ≥2 indicators of frailty.
Single-component tools were excluded due
to the multifactorial and complex nature of the
frailty syndrome).
 The study described a tool that was specifically
developed to assess frailty (tools which were
developed for alternative purposes and then
applied to measure frailty were excluded as they
do not exclusively assess frailty, but may assess
related constructs such as disability resulting in
a potentially invalid assessment of frailty and
misdiagnosis).
 The main purpose of the study was the
development and/or evaluation of the reliability
and validity of a multi-component tool to assess
frailty.
 The study applied the original version of a
multi-component tool to assess frailty (studies
citing modified versions were excluded as
reliability and validity data relate to the modified
tool only and reviewing all modified versions was
beyond the scope of this review due to the large
number of modified tools identified in the
literature).
 The study reported quantitative data (the study
must have reported inferential validation, studies
reporting descriptive data alone were excluded).
 Studies were available in English or were translated
wherever possible.
Studies were screened and selected for inclusion by
JLS.
Assessment of the methodological quality of studies and
data extraction
The COnsensus‐based Standards for the selection of
health Measurement INstruments (COSMIN) checklist
is a standardized tool for assessing the methodological
quality of studies examining the measurement properties
of health-related instruments [21–23]. It assesses meas-
urement properties in a number of domains: Internal
Consistency (the degree of the inter-relatedness among
items), Reliability (the proportion of the total variance in
measurements due to “true” differences among patients),
Measurement Error (the systematic and random error of
a patient’s score that is not attributed to true changes in
the construct to be measured), Content Validity (the
degree to which the content of an instrument is an
adequate reflection of the construct to be measured),
Construct Validity (the degree to which the scores of
an instrument are consistent with hypotheses based
on the assumption that the instrument validly measures
the construct to be measured), Criterion Validity (the de-
gree to which the scores of an instrument are an adequate
reflection of a “gold standard”) and Responsiveness (the
ability of an instrument to detect change over time in the
construct to be measured) [22]. A ‘’gold standard” meas-
urement instrument is defined in the context of the
COSMIN checklist as a valid and reliable instrument
that has been widely accepted as a gold standard by
experts in the field of its application [21–23].
Structural Validity (the degree to which the scores of
an instrument are an adequate reflection of the per-
formance of the dimensionality of the construct to be
measured), Hypothesis Testing (item construct validity;
the formulation of a hypothesis a priori with regard to
correlations between the scores on the instrument and
other variables e.g. with regard to internal relationships
or relationships with scores on other instruments) and
Cross Cultural Validity (the degree to which the perform-
ance of the items on a translated or culturally adapted
instrument are an adequate reflection of the performance
of the items of the original instrument) are assessed as
part of Construct Validity [22].
With respect to scoring, each item in the COSMIN
checklist is rated as ‘excellent’, ‘good’, ‘fair’, or ‘poor’
quality [21–23]. A rating of ‘excellent’ indicates that the
evidence provided for that measurement property is ad-
equate [21]. A rating of ‘good’ indicates that the evidence
provided can be assumed to be adequate (although all
relevant information may not be reported) [21]. Finally,
ratings of ‘fair’ and ‘poor’ indicate that the evidence pro-
vided is questionable and inadequate, respectively [21].
The COSMIN checklist was applied to each study and
data were extracted by two independent, blind raters
(JLS, RLG, MCC, AMB, EVW, SD, SPN). Any disagree-
ments were resolved through discussion. Data were then
extracted regarding the methods and outcomes of the
statistical analyses employed in each study to assess the
identified measurement properties of each assessment
tool. The outcomes of the statistical analyses employed
by each study were compared to the accepted statistical
parameters of significance for said test as identified in
medical statistics literature (see Additional file 1 foot-
note). This allowed for the identification of statistically
significant evidence of measurement properties testing.
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Reporting
This review followed the PRISMA standards [24] for
reporting of systematic reviews (see Additional file 2).
Results
Literature search and inclusion for review
Five thousand sixty-three studies were identified in total,
73 of which were included for review following assess-
ment against inclusion criteria (see Fig. 1) [2, 13, 25–95].
Study characteristics
Thirty-eight multi-component frailty assessment tools
were examined in 73 studies. The most frequently exam-
ined tool with respect to psychometric properties was the
Groningen Frailty Indicator (GFI), which was assessed in
11 studies [27, 49, 54–62]. The Tilburg Frailty Indicator
(TFI) was also frequently examined, with 9 studies in-
cluded for review [55, 57, 88–94]. Psychometric properties
were assessed in 1 study only for 22/38 tools [25, 28–30,
34, 38, 44, 48, 51–53, 63, 66–68, 71–73, 79, 86, 87, 95].
Prospective Cohort was the most frequently observed
study design (22/73 studies) [2, 13, 25–29, 31–33, 47, 48,
53, 55, 60, 66, 67, 72, 80, 81, 86, 95]. In 54/73 studies the
cohort was exclusively community-based [2, 13, 25, 26, 29,
31, 33, 34, 38–40, 45, 46, 48–50, 52–56, 59, 63–67, 70, 71,
73–95]. The country from which participants were most
commonly sampled was The Netherlands (26/73 studies)
[39, 40, 44, 49, 50, 54–63, 65, 72, 74–81, 89–93]. Follow-
up data were available for 51/73 studies; follow-up periods
varied significantly with the shortest being 1 month [35]
and the longest 348 months [33]. Data regarding the mean
age of participants were available in 55/73 studies; the
overall mean age of the participants as calculated by pool-
ing the mean ages from these 55 studies was 77.0 years
[2, 25, 27, 28, 30, 32, 33, 35–42, 44, 47–50, 52–59, 61–
65, 67–69, 72, 74–76, 79–84, 86–94]. A full outline of
study characteristics is provided in Additional file 3.
Methodological quality of studies
The results of the COSMIN checklist are summarised in
Table 1. 38/73 studies included for review had at least
one area of methodological quality rated as ‘poor’, indi-
cating inadequate quality [27, 29–35, 38–41, 43, 44, 46,
49, 51–57, 60, 61, 67–70, 74, 75, 78, 81, 82, 85, 86, 90, 94].
The measurement property that received the highest
number of poor ratings across all studies was Criterion
Validity (23/44 total ‘poor’ ratings). 52/73 studies had at
least one area of methodological quality rated as ‘fair’,
indicating questionable methodological quality [2, 13, 25,
26, 28, 30, 31, 34–39, 42, 44–50, 54–56, 60–67, 71–81, 83,
85–87, 91–93, 95]. The measurement property that
received the highest number of ‘fair’ ratings was Hypoth-
esis Testing (50/64 total ‘fair’ ratings). 2/73 studies had
one area of methodological quality scored as ‘good’, in-
dicating presumably adequate methodological quality
[57, 58]. All ratings of ‘good’ quality were awarded for
Hypothesis Testing. 6/73 studies had one area of meth-
odological quality scored as ‘excellent’, indicating adequate
methodological quality [25, 31, 54, 67, 74, 79, 84]. All
ratings of ‘excellent’ were awarded for Content Validity.
Psychometric properties of the multi-component frailty
assessment tools
Table 1 provides an overview of the measurement prop-
erties of each multi-component frailty assessment tool.
The tools that have been examined the most with respect
to psychometric domains were the TFI and GFI. The TFI
had 8 of the possible 9 domains explored (the exception
being Measurement Error) [55, 57, 88–94]. The GFI had
7/9 domains examined (the exceptions being Measure-
ment Error and Cross Cultural Validity) [27, 49, 54–62].
The tools that were examined the least with respect to
psychometric domains were Frailty predicts death One
yeaR after Elective Cardiac Surgery Test (FORECAST)
[36, 37], Guilley Frailty Instrument [63], Self-Report
Fig. 1 Process of study selection
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Table 1 Results of COnsensus‐based Standards for the selection of health Measurement Instruments (COSMIN) Checklist
Frailty assessment tool Study reference Internal
consistency
Reliability Measurement
error
Content
validity
Structural
validity
Hypotheses
testing
Cross-cultural
validity
Criterion
validity
Responsiveness Comments
9-Item Frailty Measure Ravaglia et al.
[25]
0 0 0 4 - 2 0 0 0 Structural Validity: Not rated according
to COSMIN guidance as the tool is
based on a formative model.
Brief Clinical Instrument
to Classify Frailty
Rockwood et al.
[26]
0 0 0 0 0 2 0 - 0 Criterion Validity: Study reports
assessment of criterion validity however
this is rated as part of construct validity
(hypothesis testing) according to
COSMIN guidance.
Kenig et al. [27] 0 0 0 0 0 1 0 0 0 Hypothesis Testing: Important
methodological flaws in the design of
the study noted; diagnosis of frailty via
the detection of deficits in two or more
domains of the Geriatric Assessment
(GA) has limited theoretical grounding.
No reliability or validity data for GA in
this context.
Brief Frailty Index Freiheit et al.
[28]
0 0 0 2 0 2 0 0 0
British Frailty Index Kamaruzzaman
et al. [29]
- 0 0 0 0 0 0 1 0 Internal Consistency: Not rated
according to COSMIN guidance as the
tool is based on a formative model.
Criterion Validity: The criterion
employed cannot be considered a
reasonable gold standard. Correlations
or AUC of ROC not calculated.
Care Partners-Frailty
Index-Comprehensive
Geriatric Assessment
(CP-FI-CGA)
Goldstein et al.
[30]
0 0 0 2 0 2 0 1 0 Criterion Validity: The criterion
employed cannot be considered as a
reasonable gold standard.
Clinical Frailty Scale Rockwood et al.
[31]
0 1 0 4 0 2 0 1 0 Reliability: Tool not administered by
independent raters when assessing
inter-rater reliability.
Criterion Validity: The criterion
employed cannot be considered as a
reasonable gold standard.
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Table 1 Results of COnsensus‐based Standards for the selection of health Measurement Instruments (COSMIN) Checklist (Continued)
Rockwood et al.
[32]
0 0 0 0 0 1 0 1 0 Criterion Validity: The criterion
employed cannot be considered as a
reasonable gold standard.
Criterion Validity and Hypothesis
Testing: Important methodological
flaws in the design of the study noted;
measurement properties of comparator
instrument (Phenotype of frailty-
Referred to as Frail-CHS) significantly
altered from original. No reliability or
validity data for amended version.
Mitiniski et al.
[33]
0 0 0 0 0 1 0 0 0 Construct Validity: Important
methodological flaws in the design of
the study noted; measurement
properties of comparator instrument
(Phenotype of Frailty) significantly
altered from original. No reliability or
validity data for amended version.
Clinical Global
Impression of Change
in Physical Frailty
Studenski et al.
[34]
0 1 0 2 0 0 0 0 0 Reliability: Inter-rater reliability assessed
using case scenarios. Small sample size
(n = 24) for pilot testing. Likely
selection bias in the focus group; all
patients and carers selected by first
author (all carers were female). Likely
selection bias for participants of pilot
test as the testing physicians chose two
patients who they deemed to be
frail to be tested.
Comprehensive
Assessment of Frailty
(CAF)
Sundermann
et al. [35]
0 0 0 1 - 2 0 0 0 Content validity: Some aspects of
content validity explored however
there was limited assessment of
whether all items are relevant for the
study population and limited
information regarding the theoretical
foundation of the tool.
Structural validity: Not rated according
to COSMIN guidance as the tool is
based on a formative model.
Sundermann
et al. [36]
0 0 0 0 0 2 0 0 0
Sundermann
et al. [37]
0 0 0 0 0 2 0 0 0
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Table 1 Results of COnsensus‐based Standards for the selection of health Measurement Instruments (COSMIN) Checklist (Continued)
Continuous Composite
Measure of Frailty
Buchman et al.
[38]
0 0 0 2 0 2 0 1 1 Criterion Validity: The criterion
employed cannot be considered as a
reasonable gold standard.
Measurement properties of comparator
instrument (Phenotype of Frailty)
significantly altered from original. No
reliability or validity data for amended
version.
Responsiveness: The time interval
between measurements was not
adequately described.
EASY-Care Two-step
Older persons
Screening
(Easycare TOS)
Van Kempen
et al. [39]
0 1 0 0 0 2 0 1 0 Reliability: Small sample size (n = 19) for
reliability calculations.Criterion Validity:
The criterion employed cannot be
considered as a reasonable gold
standard.
Van Kempen
et al. [40]
0 0 0 1 0 0 0 0 0 Content Validity: An assessment of
whether all items are relevant for the
purpose of the measurement
instrument was competed however
limited information available regarding
other aspects of content validity.
Edmonton Frail Scale Rolfson et al.
[41]
- 1 0 0 0 0 0 0 0 Internal Consistency: Not rated
according to COSMIN guidance as the
tool is based on a formative model.
Reliability: Small sub sample size (n = 18)
for reliability calculations.
Haley et al. [42] 0 0 0 0 0 2 0 0 0
Graham et al.
[43]
0 0 0 0 0 1 0 0 0 Hypothesis Testing: Important
methodological flaws in the design of
the study noted; tertile split was
performed for reasons of sample size
equality and not theoretically or
empirically justified.
Evaluative Index for
Physical Frailty
De Vries et al.
[44]
0 1 0 2 0 1 0 0 0 Reliability and Hypothesis testing: Small
sample (n = 24)
Frailty Index-
Comprehensive
Geriatric Assessment
(FI-CGA)
Jones et al. [45] 0 2 0 2 0 2 0 0 0
Jones et al. [46] 0 0 0 0 0 2 0 1 0 Criterion Validity: The criterion
employed cannot be considered as a
reasonable gold standard.
Pilotto et al.
[47]
0 0 0 0 0 2 0 0 0
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Table 1 Results of COnsensus‐based Standards for the selection of health Measurement Instruments (COSMIN) Checklist (Continued)
FORECAST Sundermann
et al. [35]
0 0 0 0 0 2 0 0 0
Sundermann
et al. [36]
0 0 0 0 0 2 0 0 0
Frailty Index Mitnitski et al.
[48]
0 0 0 0 0 2 0 0 0
Frailty Index based on
Primary Care Data.
Drubbel et al.
[49]
0 0 0 2 0 2 0 1 0 Criterion Validity: The criterion
employed cannot be considered as a
reasonable gold standard.
Drubbel et al.
[50]
0 0 0 2 0 2 0 0 0
Frailty Index for Elders
(FIFE)
Tocchi et al.
[51]
- 0 0 1 - 0 0 0 0 Internal Consistency & Structural
Validity: Not rated according to
COSMIN guidance as the tool is based
on a formative model.
Content Validity: Important
methodological flaws in the design of
the study noted; during item
generation process potential variables
excluded solely on the basis of
information available in the parent
data set.
Frail Non-Disabled
Instrument (FiND)
Cesari et al. [52] 0 0 0 1 0 1 0 1 0 Content Validity, Hypothesis Testing
and Criterion Validity: Important
methodological flaws in the design of
the study noted; Analysis of agreement
between FiND and Phenotype of
Frailty is flawed as FiND includes 2/5 of
the Phenotype of Frailty items. This
significantly affects the interpretation
of the data.
Frailty Screening Tool Doba et al. [53] 0 0 0 1 - 1 0 0 0 Structural Validity: Not rated according
to COSMIN guidance as the tool is
based on a formative model.
Content validity & Hypothesis Testing:
Important methodological flaws in the
design of the study noted; potential
selection bias due to the exclusion of
those older adults who had chronic
comorbid illness. Potential
underrepresentation of frailest adults
due to the exclusion of participants
from analysis whom were unable to
engage in a final assessment. No clarity
regarding the definition of ’cognitive
change’ item.
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Table 1 Results of COnsensus‐based Standards for the selection of health Measurement Instruments (COSMIN) Checklist (Continued)
Groningen Frailty
Indicator (GFI)
Bielderman
et al. [54]
- 0 0 4 - 2 0 1 0 Internal Consistency and Structural
Validity: Not rated according to
COSMIN guidance as the tool is based
on a formative model.
Criterion Validity: The criterion
employed cannot be considered as a
reasonable gold standard.
Daniels et al.
[55]
0 0 0 0 0 2 0 1 2 Criterion Validity: The criterion
employed cannot be considered as a
reasonable gold standard.
Drubbel et al.
[49]
0 0 0 0 0 2 0 1 0 Criterion Validity: The criterion
employed cannot be considered as a
reasonable gold standard.
Hoogendijk
et al. [56]
0 0 0 0 0 2 0 1 0 Criterion Validity: The criterion
employed cannot be considered as a
reasonable gold standard.
Kenig et al. [27] 0 0 0 0 0 1 0 0 0 Hypothesis Testing: Important
methodological flaws in the design of
the study noted; diagnosis of frailty via
the detection of deficits in two or
more domains of the Geriatric
Assessment has limited theoretical
grounding. No reliability or validity
data for GA in this context.
Metzelthin et al.
[57]
- 0 0 0 - 3 0 1 0 Internal Consistency and Structural
Validity: Not rated according to
COSMIN guidance as the tool is based
on a formative model.
Criterion Validity: The criterion
employed cannot be considered as a
reasonable gold standard.
Peters et al. [58] - 0 0 0 - 3 0 0 0 Internal Consistency and Structural
Validity: Not rated according to
COSMIN guidance as the tool is based
on a formative model.
Schuurmans
et al. [59]
0 0 0 0 0 2 0 0 0
Smets et al. [60] 0 0 0 0 0 2 0 1 0 Criterion Validity: The criterion
employed cannot be considered as a
reasonable gold standard.
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Table 1 Results of COnsensus‐based Standards for the selection of health Measurement Instruments (COSMIN) Checklist (Continued)
Steverink et al.
[61]
- 1 0 1 0 2 0 0 0 Internal Consistency: Not rated
according to COSMIN guidance as the
tool is based on a formative model.
Reliability: Limited information
regarding basic inter-rater reliability
calculations given. No further reliability
calculations completed.
Content Validity: Limited assessment of
whether all items are relevant for the
study population. Limited information
due to source being a poster
presentation abstract.
Tegels et al.
[62]
0 0 0 0 0 2 0 0 0
Guilley Frailty
Instrument
Guilley et al.
[63]
0 0 0 0 0 2 0 0 0
Inactivity and Weight
Loss
Chin et al. [64] 0 0 0 2 0 2 0 0 0
Chin et al. [65] 0 0 0 0 0 2 0 0 0
INTER-FRAIL Study
Questionnaire
De Bari et al.
[66]
0 0 0 2 0 2 0 0 0
KLoSHA Frailty Index Jung et al. [67] 0 0 0 4 - 2 0 1 0 Structural Validity: Not rated according
to COSMIN guidance as the tool is
based on a formative model.
Criterion Validity: The criterion
employed cannot be considered as a
reasonable gold standard.
Marigliano–Cacciafesta
Polypathological Scale
Amici et al. [68] 0 0 0 0 0 1 0 1 0 Hypothesis testing and Criterion
Validity: Important methodological
flaws in the design of the study noted;
analysis consists purely of correlations
with limited theoretical justification.
Criterion Validity: The criterion
employed cannot be considered as a
reasonable gold standard.
Phenotype of Frailty Esrund et al. [2] 0 0 0 0 0 2 0 0 0
Fried et al. [13] 0 0 0 0 0 2 0 0 0
Kenig et al. [27] 0 0 0 0 0 1 0 0 0 Hypothesis Testing: Important
methodological flaws in the design of
the study noted; diagnosis of frailty via
the detection of deficits in two or
more domains of the Geriatric
Assessment has limited theoretical
grounding. No reliability or validity
data for GA in this context.
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Table 1 Results of COnsensus‐based Standards for the selection of health Measurement Instruments (COSMIN) Checklist (Continued)
Kim et al. [69] 0 0 0 0 0 0 0 1 0 Criterion Validity: The criterion
employed cannot be considered as a
reasonable gold standard. No
calculations of sensitivity and
specificity.
Kulminski et al.
[70]
0 0 0 0 0 0 0 1 0 Criterion Validity: The criterion
employed cannot be considered as a
reasonable gold standard. Scoring
changed from ordinal to continuous
however only relative risk ratios were
compared. No correlations or AUC of
ROC calculated.
Predictive Physical
Frailty Score
Carriere et al.
[71]
0 0 0 0 - 2 0 0 0 Structural Validity: Not rated according
to COSMIN guidance as the tool is
based on a formative model.
Prognostic Risk Score Pijpers et al.
[72]
0 0 0 0 - 2 0 0 0 Structural Validity: Not rated according
to COSMIN guidance as the tool is
based on a formative model.
Self-Report Screening
Tool for Frailty
De Souto
Barreto et al.
[73]
0 0 0 0 0 2 0 0 0
SHARE Frailty
Instrument
Romero-Ortuno
et al. [74]
0 0 0 4 - 2 0 1 0 Structural Validity: Not rated according
to COSMIN guidance as the tool is
based on a formative model.
Criterion Validity: The criterion
employed cannot be considered as a
reasonable gold standard.
Romero-Ortuno
et al. [75]
0 0 0 0 0 2 0 1 0 Criterion Validity: The criterion
employed cannot be considered as a
reasonable gold standard.
Romero-Ortuno
et al. [76]
0 0 0 0 0 2 0 0 0
Romero-Ortuno
et al. [77]
0 0 0 0 0 2 0 0 0
Romero-Ortuno
et al. [78]
0 0 0 0 0 2 0 1 0 Criterion Validity: The criterion
employed cannot be considered as a
reasonable gold standard.
SHARE Frailty
Instrument 75+
(SHARE-FI75+)
Romero-Ortuno
et al. [79]
- 0 0 4 - 2 0 0 0 Internal Consistency & Structural
Validity: Not rated according to
COSMIN guidance as the tool is based
on a formative model.
SOF Frailty Criteria Bilotta et al.
[80]
0 0 0 0 0 2 0 0 0
Sutton
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Table 1 Results of COnsensus‐based Standards for the selection of health Measurement Instruments (COSMIN) Checklist (Continued)
Ensrud et al.
[81]
0 0 0 0 0 2 0 1 0 Criterion Validity: The criterion
employed cannot be considered as a
reasonable gold standard.
Strawbridge Frailty
Measure
Strawbridge
et al. [82]
0 0 0 1 0 0 0 0 0 Content validity: No assessment of
whether all items are relevant for the
target population and no assessment
of whether all items together
comprehensively reflect the
measurement of frailty.
Matthews et al.
[83]
0 0 0 0 0 2 0 0 0
The Comprehensive
Frailty Assessment
Instrument
De Witte et al.
[84]
- 0 0 4 - 0 0 0 0 Internal Consistency & Structural
Validity: Not rated according to
COSMIN guidance as the tool is based
on a formative model.
De Witte et al.
[85]
- 0 0 0 0 2 0 1 0 Internal consistency: Not rated
according to COSMIN guidance as the
tool is based on a formative model.
Criterion Validity: The criterion
employed cannot be considered as a
reasonable gold standard.
The Frailty Trait Scale Garcia-Garcia
et al. [86]
0 0 0 2 0 2 0 1 0 Criterion Validity: The criterion
employed cannot be considered as a
reasonable gold standard.
The FRAIL Scale Lopez et al. [87] 0 0 0 0 0 2 0 0 0
Tilburg Frailty Indicator
(TFI)
Andreasen
et al. [88]
0 0 0 0 0 0 1 0 0 Cross-Cultural Validity: Sample size less
than 5 times the number of items
included on the scale (5* 15 = 75,
actual sample size included; 34)
Daniels et al.
[55]
0 0 0 0 0 2 0 1 2 Criterion Validity: The criterion
employed cannot be considered as a
reasonable gold standard.
Gobbens & van
Assen [89]
0 0 0 0 0 2 0 0 0
Gobbens et al.
[90]
0 0 0 1 0 0 0 0 0 Content Validity: An assessment of
whether all items are relevant for the
purpose of the measurement
instrument was competed however
there was limited information
regarding other aspects of content
validity.
Gobbens et al.
[91]
0 2 0 2 0 2 0 0 0
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Table 1 Results of COnsensus‐based Standards for the selection of health Measurement Instruments (COSMIN) Checklist (Continued)
Gobbens et al.
[92]
0 0 0 0 0 2 0 0 0
Gobbens et al.
[93]
0 0 0 0 0 2 0 0 0
Metzelthin et al.
[57]
- 0 0 0 - 3 0 1 0 Internal Consistency and Structural
Validity: Not rated according to
COSMIN guidance as the tool is based
on a formative model.
Criterion Validity: The criterion
employed cannot be considered as a
reasonable gold standard.
Uchmanowicz
et al. [94]
- 0 0 0 0 0 1 0 0 Internal Consistency: Not rated
according to COSMIN guidance as the
tool is based on a formative model.
Cross Cultural Validity: Multiple-group
confirmatory factor analysis not
performed.
WHIOS Multicomponent
Measure
Woods et al.
[95]
0 0 0 0 0 2 0 0 0
Key: 4: Excellent, 3: Good, 2: Fair, 1: Poor, 0: No information, − : Not rated
AUC Area Under Curve, ROC Receiver Operating Curve
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Screening Tool for Frailty [73], The Fatigue Resistance
Ambulation Illnesses Loss of Weight (FRAIL) Scale
[87] and Women's Health Initiative Observational Study
(WHIOS) Multicomponent Measure [95]. Each of these
tools had only one element of Construct Validity (Hypoth-
esis Testing) explored.
Overall Internal Consistency was assessed in 7/38 tools
[29, 41, 51, 54, 57, 58, 61, 79, 84, 85, 94]; Internal
Consistency was determined via Cronbach α calculations
for 6/7 tools, the scores of which ranged from 0.62 for
the Edmonton Frail Scale (EFS) [42] to 0.81 for The Com-
prehensive Frailty Assessment Instrument [84]. Reliability
was assessed in 8/38 tools [31, 34, 39, 41, 44, 45, 61, 91].
Inter-rater reliability was assessed for 8/38 tools [31, 34,
39, 41, 44, 45, 61, 91] and was most commonly assessed
using Cohen’s Kappa calculations, the scores of which
ranged from 0.63 for the Easycare- Two-step Older per-
sons Screening (EASY-Care TOS) [39] to 0.72 for the
Evaluative Index for Physical Frailty (EIPF) [44]. Intra-
rater reliability was assessed for the EIPF only using
Cohen’s Kappa calculations and Intraclass Correlation
Coefficient calculations [44]. Test-retest reliability was
assessed for the TFI only using Pearson Correlation
Coefficient calculations [91]. Measurement Error was
not assessed for any tool.
Construct Validity was the most widely evaluated
measurement property, and was assessed in 36/38 tools
[2, 13, 25–28, 30–33, 35–95]. The Clinical Global Im-
pression of Change in Physical Frailty [34] and the British
Frailty Index (BFI) [29] were the only tools for which
Construct Validity was not assessed. Structural Validity
was assessed in 12/38 tools [25, 35, 51, 53, 54, 57, 58, 67,
71, 72, 74, 79, 84]. Exploratory and Confirmatory Factor
Analysis were the most common statistical methods
employed to determine structural validity. Hypothesis
Testing was assessed in 33/38 tools [2, 13, 25–28,
30–33, 35–39, 42–50, 52–68, 71–81, 83, 85–87, 89,
91–93, 95]. Hazard and Odds Ratios were the most
frequently employed method of statistical analysis used to
establish predictive validity as part of Hypothesis Testing.
Cross Cultural Validity was assessed in one tool; the TFI
[88, 94]. Content Validity was assessed in 28/38 tools
[25, 28, 30, 31, 34, 35, 38, 40, 44, 45, 49–54, 61, 66,
67, 74, 79, 82, 84, 86, 90, 91]. Criterion Validity was
assessed in 18/38 tools [26, 29–32, 38, 39, 46, 49, 52,
54–57, 60, 67–70, 74, 75, 78, 81, 85, 86]. Receiver
Operating Characteristic curve analysis was the most
frequently employed method of statistical analysis to
determine Criterion Validity. Responsiveness was assessed
in 2/38 tool; the GFI and TFI [55]. Additional file 1 pro-
vides an overview of the statistical analysis employed in
each study to assess the identified measurement properties.
Table 2 summarises the measurement properties eval-
uated for each tool for which the supporting evidence
was within statistically significant parameters and the
evidence was rated as ‘fair’, ‘good’ or ‘excellent’ according
to the COSMIN checklist. Evidence of Internal Consistency
and Structural Validity was excluded following COSMIN
guidance as items of a measurement tool do not need
to be correlated when a tool is based on a formative
model [21–23].
In terms of the individual measurement properties that
were evaluated, 2/38 frailty assessment tools had Reliabil-
ity data within statistically significant parameters of fair-
excellent quality; the FI-CGA [45–47] and TFI [45, 91].
18/38 tools had Content Validity of fair-excellent quality
within statistically significant parameters [25, 26, 30–38,
44–47, 49, 50, 54–62, 64–67, 74–79, 84–86, 88–94]. 30/38
tools had evidence for Hypothesis Testing [2, 13, 25–28,
30–32, 35–39, 42, 45–50, 54–67, 71–81, 83, 85–87, 89,
91–93, 95] and 2/38 had evidence of Responsiveness; the
GFI and TFI [55].
The TFI and the FI-CGA were the only tools which
had both reliability and validity data within statistically
significant parameters of fair-excellent quality [45–47,
55, 57, 88–94]. The TFI had acceptable evidence of psy-
chometric testing for 4 measurement domains; Reliability,
Content Validity, Hypothesis Testing and Responsiveness.
The FI-CGA had acceptable evidence of psychometric
testing for 3 measurement domains; Reliability, Content
Validity and Hypothesis Testing. The following tools were
found to have no reliability or validity evidence of fair-
excellent quality within statistically significant parameters;
BFI [29], EFS [41, 42], Frailty Index for Elders [51], Frail
Non-Disabled Instrument [52], Frailty Screening Tool
[53], Marigliano–Cacciafesta Polypathological Scale [68]
and Strawbridge Frailty Measure [82, 83].
Discussion
To the authors’ knowledge this is the first review of the
overall reliability and validity of multi-component frailty
assessment tools that were specifically developed to assess
frailty in older adult populations. This review presents a
comprehensive list of multi-component frailty assessment
tools for which there are published psychometric data.
Whilst 73 papers met the inclusion criteria for review,
many more were excluded as they directly or indirectly
reported on the psychometric evaluation of an amended
version of an established frailty assessment tool. This
was predominantly observed in relation to the CHS
Phenotype Model [13] and the CSHA Cumulative Deficit
Model [14], where modified versions of Fried’s Pheno-
type of Frailty tool and Mitinski’s Frailty Index were
applied. While evidence from such studies supports the
robustness of these models to conceptualise frailty, it
does not provide evidence for the reliability or validity of
the original assessment tool. This application of non-
standardised versions of frailty assessment tools within
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Table 2 A summary of the measurement properties of multicomponent frailty assessment tools with evidence of reliability and
validity that was within statistical significant parameters and of fair to excellent quality
Frailty assessment tool Internal
consistency
Reliability Measurement
error
Content
validity
Structural
validity
Hypothesis
testing
Cross cultural
validity
Criterion
validity
Responsiveness
9-Item Frailty Measure [25] X X
Brief Clinical Instrument to
Classify Frailty [26, 27]
X
Brief Frailty Index [28] X X
British Frailty Index [29]
Care Partners-Frailty Index-
Comprehensive Geriatric
Assessment [30]
X X
Clinical Frailty Scale [31–33] X X
Clinical Global Impression of
Change in Physical Frailty [34]
X
Comprehensive Assessment of
Frailty [35–37]
X
Continuous Composite Measure
of Frailty [38]
X X
EASY-Care Two-step Older
persons Screening [39, 40]
X
Edmonton Frail Scale [41–43]
Evaluative Index for Physical
Frailty [44]
X
FI-CGA [45–47] X X X
FORECAST [35, 36] X
Frailty Index [48] X
Frailty Index based on Primary
Care Data [49, 50]
X X
Frailty Index for Elders [51]
Frail Non-Disabled Instrument
[52]
Frailty Screening Tool [53]
Groningen Frailty Indicator
[27, 49, 54–62]
X X X
Guilley Frailty Instrument [63] X
Inactivity and Weight Loss
[64, 65]
X X
INTER-FRAIL Study Questionnaire
[66]
X X
KLoSHA Frailty Index [67] X X
Marigliano–Cacciafesta
Polypathological Scale [68]
Phenotype of Frailty
[2, 13, 27, 69, 70]
X
Predictive Physical Frailty Score
[71]
X
Prognostic Risk Score [72] X
Self-Report Screening Tool for
Frailty [73]
X
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frailty research significantly limits conclusions that can
be drawn regarding reliability and validity. It is notable
that the CSHA Cumulative Deficit Model is not pre-
scriptive regarding the exact age-related deficits to be
included in a Frailty Index, nor the exact number of
deficits [14]. A wide range of non-standardised Frailty
Indexes were identified in the literature, which was
outside of the scope of this review to explore; a recent
systematic review by Drubbel et al. [18] specifically
explored the criterion validity, construct validity and
responsiveness of the Frailty Indexes when applied in a
community-dwelling older adult population.
It was observed that many of the frailty assessment
tools included for review were developed and tested retro-
spectively using data available from large-scale longitu-
dinal studies or were developed in conjunction with a
larger trial; the main aim of which was not the develop-
ment of a frailty assessment tool. This lack of focused
primary research may partly explain why there are limited
reliability and validity data of high quality for many of the
tools identified.
In summary, the GFI and TFI were the most frequently
examined tools with respect to psychometric properties
(11 and 9 studies respectively). 22/38 tools identified had
only 1 study concerning psychometric properties; this lim-
ited evidence-base reduces the generalisability of the re-
sults and conclusions that can be drawn.
Health measurement instruments must be both reliable
and valid to ensure diagnostic accuracy and consistency in
measurement [23]. Of the 38 multi-component frailty
assessment tools identified, no tool has been examined in
all reliability and validity domains assessed by the COS-
MIN checklist. The TFI and GFI had the most psychomet-
ric domains explored (8/9 and 7/9 domains, respectively).
However, not all of this evidence was assessed to be of
fair-excellent quality within statistically significant
parameters. Only the TFI and FI-CGA had reliability and
validity data within statistically significant parameters of
fair-excellent quality. The TFI had acceptable evidence of
psychometric testing for 4 measurement domains, while
the FI-CGA had acceptable evidence of psychometric test-
ing for 3 measurement domains.
Research and clinical implications
The frailty assessment tool that has been most extensively
examined in terms of its psychometric properties and has
the most robust evidence supporting its reliability and
validity is the TFI. However, for a frailty assessment tool
to meet the requirements of a gold standard it must be
based on a universally accepted operational definition of
frailty and have evidence pertaining to all aspects of the
tool’s reliability and validity of high methodological quality
[9]. Further research of good-excellent quality is needed,
encompassing all aspects of reliability and validity, before
the TFI tool can be classified as a gold standard.
The application of a tool without a strong evidence-
base of reliability and validity significantly increases the
risk of invalid assessment and misdiagnosis of frailty.
The consequent implications for research are substantial,
including an increased likelihood of the interpretation
and reporting of flawed results. The implications for
treatment provision and patient outcomes in a clinical
setting are also substantial; with potential for decreased
recognition of risks for adverse outcomes, inappropriate
treatment planning and inappropriate allocation of re-
sources including unsuitable provision of preventative and
restorative interventions. Therefore, the scope and quality
of reliability and validity evidence must be considered
when selecting an assessment tool in both settings. Other
key considerations that are important to note when select-
ing a frailty assessment tool are the interpretability and
generalisability of the evidence-base. Evidence of the
Table 2 A summary of the measurement properties of multicomponent frailty assessment tools with evidence of reliability and
validity that was within statistical significant parameters and of fair to excellent quality (Continued)
SHARE Frailty Instrument [74–78] X X
SHARE Frailty Instrument 75+
[79]
X X
SOF Frailty Criteria [80, 81] X
Strawbridge Frailty Measure
[82, 83]
The Comprehensive Frailty
Assessment Instrument [84, 85]
X X
The Frailty Trait Scale [86] X X
The FRAIL Scale [87] X
Tilburg Frailty Indicator (TFI)
[55, 57, 88–94]
X X X X
WHIOS Multicomponent Measure
[95]
X
Sutton et al. BMC Geriatrics  (2016) 16:55 Page 16 of 20
reliability and validity of an assessment tool relates only to
its application within the specific setting and population
that it was developed for and validated in. The utility of
the tool should also be considered, specifically the appro-
priateness of the mode of administration in relation to the
setting and the time and resource demands associated
with the tool.
The development and psychometric evaluation of frailty
assessment tools should be the primary focus of research
projects to further develop a strong evidence-base. When
evaluating existing tools, studies should apply a standar-
dised version where feasible. The consensus on a univer-
sally accepted operational definition of frailty should also
be a key focus of future frailty research to support the de-
velopment of a gold standard frailty assessment tool.
Limitations of the review
The selection of studies for inclusion was completed by
the lead author (JLS) only, which increased the potential
for selection bias; this risk was minimised by following a
comprehensive search strategy and the PRISMA standards
for reporting in systematic reviews [24]. Studies examining
tools that were not specifically developed to assess frailty
were excluded; this resulted in the exclusion of some tools
such as the Short Physical Performance Battery [96] and
Comprehensive Geriatric Assessment [97] which have
been referred to in the frailty literature as tools with
potential utility in assessing frailty as part of a wider
comprehensive assessment. This limits the scope of this
review, but was considered reasonable given the com-
plexity of the frailty syndrome. Studies which directly
or indirectly reported on the psychometric evaluation
of an amended version of an established frailty assess-
ment tool were also excluded. This again limits the
scope of the review but was considered reasonable due
to the large number of studies citing modified tools
identified in the literature and the large variation in the
types of modifications.
The COSMIN checklist has several limitations in its
application. When assessing Criterion Validity the
COSMIN checklist requires the comparator tool to be of
a gold standard. There is currently no gold standard
frailty assessment tool. Thus, whilst the majority of
studies included for review assessing Criterion Validity
compared one frailty assessment tool to another widely-
used tool, the COSMIN guidance stipulated that this
should be rated as evidence of poor methodological qual-
ity in relation to Criterion Validity. The COSMIN guid-
ance does however allow for this relationship between
frailty assessment tools to be rated as part of Construct
Validity, so the evidence of validity provided by such stud-
ies was still represented in the COSMIN scoring system.
With regards to the COSMIN scoring system, the
overall methodological quality rating per measurement
property is obtained by taking the lowest rating of all
the items assessed for that property giving a ‘worst
counts score’ [21–23]. Occasionally, however, a measure-
ment property scored highly for all items assessed except
for one which resulted in a ‘poor’ overall score which did
not accurately reflect all the presented evidence. Such a
measurement property received the same overall rating as
measurement properties that had entirely poor ratings for
all items. It was not within the scope of this systematic
review to differentiate between such ratings on an item by
item basis when reporting results. Whilst this is a limita-
tion, receiving a rating of ‘poor’ for one item is an indica-
tion of inadequate methodological quality so it does not
impact on the overall quality assessment. The application
of the COSMIN checklist; a standardised tool developed
specifically to assess the methodological quality of studies
examining the measurement properties of health-related
instruments remains a strength of this review.
Conclusions
This review provides an up-to-date comprehensive list
of all multi-component frailty assessment tools for which
there is published psychometric data. It identifies a large
number of multi-component frailty assessment tools in
existence; however, the breadth and quality of the psy-
chometric properties of these tools is limited. Only the
FI-CGA [45–47] and TFI [54, 56, 86–94] have both
reliability and validity data within statistically significant
parameters and of fair-excellent quality. However, this
should be interpreted with caution as a score of ‘fair’ on
the COSMIN checklist means that the evidence is only
of questionable quality. At present, the TFI has the most
robust evidence-base supporting its reliability and validity
in assessing frailty. However, the psychometric properties
of the TFI and all other multi-component frailty assess-
ment tools require further in-depth evaluation before they
can fulfil the criteria for a gold standard assessment tool,
and before definitive conclusions regarding the best tool
for use in research and clinical settings can be drawn.
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